CORRELATION OF SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS WITH VISUAL ACUITY IN EYES WITH SUBFOVEAL SCARRING AFTER TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION

Purpose: Correlating spectral domain optical coherence tomography characteristics with final best-corrected visual acuity (BCVA) in eyes with subfoveal scarring after treatment for wet age-related macular degeneration. Methods: Seventy-nine eyes from 64 subjects, who developed subfoveal scarring after treatment of wet age-related macular degeneration, were retrospectively studied. Spectral domain optical coherence tomography characteristics were analyzed, including percentage disruption of inner segment/outer segment junction and external limiting membrane, central macular thickness, subfoveal scar thickness, subretinal scar area, and proximity of retina with intact outer structures to the fovea. A multivariate stepwise regression analysis was performed with the final BCVA logarithm of minimum angle of resolution as a response and the above-identified spectral domain optical coherence tomography variables as predictors. Results: There was no correlation between the final BCVA and any of the demographic data, treatment modality received, and central macular thickness. The final BCVA was significantly correlated with the percentage of inner segment/outer segment disruption (P = 0.011), external limiting membrane disruption (P = 0.005), and scar area on spectral domain optical coherence tomography (P = 0.018). Multivariate analysis showed that the baseline BCVA and distance between the fovea and nearest retina with intact outer structures are the most predictive of the final BCVA (R2 = 0.52). Conclusion: Baseline BCVA and integrity of outer retinal structures are good predictors of the final BCVA of wet age-related macular degeneration patients developing scarring after treatment.

[1]  Wei-Chi Wu,et al.  PREDICTIVE FACTORS FOR VISUAL OUTCOME TO INTRAVITREAL BEVACIZUMAB IN YOUNG CHINESE PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION , 2011, Retina.

[2]  Hyewon Chung,et al.  ASSOCIATION BETWEEN FOVEAL MICROSTRUCTURE AND VISUAL OUTCOME IN AGE-RELATED MACULAR DEGENERATION , 2011, Retina.

[3]  J. Jonas,et al.  Bilateral intravitreal bevacizumab injection for exudative age-related macular degeneration: effect of baseline visual acuity. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[4]  J. García-Feijóo,et al.  Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment. , 2011, American journal of ophthalmology.

[5]  P. Rosenfeld,et al.  Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. , 2011, Ophthalmology.

[6]  P. Keane,et al.  Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.

[7]  H. Koh,et al.  Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration , 2010, Japanese Journal of Ophthalmology.

[8]  Masayuki Hata,et al.  The significance of external limiting membrane status for visual acuity in age-related macular degeneration. , 2010, American journal of ophthalmology.

[9]  W. Freeman,et al.  The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. , 2010, American journal of ophthalmology.

[10]  S. Kishi,et al.  CORRELATION BETWEEN VISUAL ACUITY AND FOVEAL MICROSTRUCTURAL CHANGES IN DIABETIC MACULAR EDEMA , 2010, Retina.

[11]  W. Freeman,et al.  DISRUPTION OF THE PHOTORECEPTOR INNER SEGMENT/OUTER SEGMENT LAYER ON SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY IS A PREDICTOR OF POOR VISUAL ACUITY IN PATIENTS WITH EPIRETINAL MEMBRANES , 2010, Retina.

[12]  K Bailey Freund,et al.  Outer retinal tubulation: a novel optical coherence tomography finding. , 2009, Archives of ophthalmology.

[13]  Srinivas R Sadda,et al.  Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[14]  A. Tsujikawa,et al.  Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. , 2009, American journal of ophthalmology.

[15]  G. Ripandelli,et al.  RETINAL FUNCTIONAL CHANGES MEASURED BY MICROPERIMETRY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS TREATED WITH RANIBIZUMAB , 2009, Retina.

[16]  Y. Tano,et al.  Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. , 2009, Ophthalmology.

[17]  P. Kaiser,et al.  Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration , 2009, British Journal of Ophthalmology.

[18]  Y Mitamura,et al.  Correlation between visual function and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa , 2009, Eye.

[19]  I. Maruko,et al.  Morphologic changes in the outer layer of the detached retina in rhegmatogenous retinal detachment and central serous chorioretinopathy. , 2009, American journal of ophthalmology.

[20]  P. Keane,et al.  Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. , 2008, Ophthalmology.

[21]  Yoshinori Mitamura,et al.  CORRELATION OF VISUAL RECOVERY AND PRESENCE OF PHOTORECEPTOR INNER/OUTER SEGMENT JUNCTION IN OPTICAL COHERENCE IMAGES AFTER SUCCESSFUL MACULAR HOLE REPAIR , 2008, Retina.

[22]  Paul G. Updike,et al.  Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. , 2008, Ophthalmology.

[23]  Peter K Kaiser,et al.  Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.

[24]  C. Regillo,et al.  Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. , 2007, American journal of ophthalmology.

[25]  Danjie Li,et al.  Loss of photoreceptor outer segment in acute zonal occult outer retinopathy. , 2007, Archives of ophthalmology.

[26]  T. Yatagai,et al.  [Improved visualization of foveal pathologies using fourier-domain optical coherence tomography]. , 2007, Nippon Ganka Gakkai zasshi.

[27]  A. Tsujikawa,et al.  Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion , 2007, British Journal of Ophthalmology.

[28]  T. Yatagai,et al.  Three-dimensional imaging of macular holes with high-speed optical coherence tomography. , 2007, Ophthalmology.

[29]  K. Eng,et al.  Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.

[30]  R. Avery,et al.  Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. , 2006, Ophthalmology.

[31]  J. Slakter,et al.  Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. , 2006, Ophthalmology.

[32]  M. Sandberg,et al.  The association between visual acuity and central retinal thickness in retinitis pigmentosa. , 2005, Investigative ophthalmology & visual science.

[33]  Miguel J Maldonado,et al.  Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. , 2005, American journal of ophthalmology.

[34]  I. Immonen,et al.  Visual acuity and structural findings in old age-related macular degeneration , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[35]  G. Ravera,et al.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.

[36]  I. Immonen,et al.  Predictors of structural findings in old disciform lesions. , 2004, American journal of ophthalmology.

[37]  Johanna M Seddon,et al.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.

[38]  J. Winder,et al.  Identification of lesion components that influence visual function in age related macular degeneration , 2003, The British journal of ophthalmology.

[39]  L. Yannuzzi,et al.  CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2003, Retina.

[40]  Neil M Bressler,et al.  Retinal arteriolar narrowing and risk of coronary heart disease. , 2003, Archives of ophthalmology.

[41]  U Chakravarthy,et al.  Relation between macular morphology and visual function in patients with choroidal neovascularisation of age related macular degeneration , 2001, The British journal of ophthalmology.

[42]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[43]  T. Stokkermans,et al.  Treatment of age-related macular degeneration. , 2000, Clinical eye and vision care.

[44]  J T Holladay,et al.  Proper method for calculating average visual acuity. , 1997, Journal of refractive surgery.

[45]  Myron Yanoff,et al.  Textbook of Ophthalmology , 1938, The Indian Medical Gazette.